July 17, 2026

In brain tumors, CAR studies targeting six different antigens (EGFR, EGFRvIII, EphA2, Her2, IL13R, and MUC1) are ongoing (NCT02331693, NCT01454596, NCT02575261, NCT02442297, NCT02208362, NCT02617134), using second (CD28 or 41BB costimulation) or third (CD28 and 41BB costimulation) generation constructs (Table2)

In brain tumors, CAR studies targeting six different antigens (EGFR, EGFRvIII, EphA2, Her2, IL13R, and MUC1) are ongoing (NCT02331693, NCT01454596, NCT02575261, NCT02442297, NCT02208362, NCT02617134), using …

In Fig

In Fig.?6, the nude mice were injected through the tail vein with MM.1R cells, and the subsequent xenograft tumor tissues from the lungs were isolated …